DNAe, the Next-Generation Sequencing (NGS) company developing a transformative fully automated, sample-to-report diagnostics platform, today unveils a new Early Access Program, offering clinical ...

Explore trends before investing – request a sample report today! The Non-NGS Predictive Cancer Diagnostics Market is ...

A few years ago, a new NGS platform being announced at the Advances in Genome Biology and Technology (AGBT) meeting would not have been a surprise; multiple new instruments entered the NGS arena over ...

Roche's innovative sequencing by expansion (SBX) technology represents a leap forward in next-generation sequencing (NGS), which is playing a vital role in decoding complex diseases like cancer, ...

The global genomics market is set to expand from USD 47.07 billion in 2025 to USD 85.09 billion by 2030, with a CAGR of 12.6% ...

The next generation sequencing market offers significant opportunities by enhancing the diagnosis and treatment of chronic ...

Normalization by Ligation™ library preparation technology processes thousands of samples at low cost with enhanced multiplexing and novel streamlined workflow SOUTH SAN FRANCISCO, Calif.--(BUSINESS ...

Researchers rely on next-generation sequencing (NGS) to interrogate DNA, RNA, and other analytes in a high throughput manner. As NGS technology advances, so does sequencing capacity. To keep up to ...

Expertise from Forbes Councils members, operated under license. Opinions expressed are those of the author. Advances in next generation sequencing (NGS) technologies have enabled cancer research ...

DNAe, the Next-Generation Sequencing (NGS) company developing a transformative fully automated, sample-to-report diagnostics platform, today unveils a new Early Access Program, offering clinical partn ...